Award Global Co. Ltd
13 Olawale Dawodu Street, Ifako Gbagada, Lagos, Nigeria
Tel: 01-4827414

Brand Name



Tuton Pharmaceuticals 85, G.I.D.C. Naroda. Ahmedbad 38 330. Gujarat, India

Therapeutic Class

Anti-infective/Corticosteroid combinations, Skin

Dosage Form, Composition & NAFDAC Registration Number (NRN)

Cream (NRN: ): Each gram contains: Econazole Nitrate B.P. 10 mg TriamcinoIone Acetonide B.P. 1.0 mg Gentamicin Sulphate B.P 1.0 mg Cream base q.s.

Pack Size: 20 g tube.



Acneaclear Cream contains dermatomycosis agent i.e. antifungal, antibiotic and corticosteroid. It is well absorbed on topical application.

• Econazole nitrate is a broad-spectrum antifungal agent with activity against many gram-positive bacteria.

• Triamcinolone acetonide is a potent corticosteroid with anti-inflammatory, antipruritic activity.

• Gentamicin sulphate is wide-spectrum antibiotic, which provides highly effective treatment in primary and secondary bacterial infections of the skin.


For the topical treatment of inflammatory dermatomycoses and inflammatory skin conditions complicated by bacterial or fungal skin infection.

• Allergic inflammatory dermatoses (eczema, dermatitis, diaper dematitis, intertrigo, etc)

• Trychophytosis: tinea pedis, tinea corporis, tinea feciei, tinea cruds, tinea sycosis.

• Tinea versicolor

• Skin candidiasis

• Bacterial skin infections caused by susceptible strains to Gentamicin.


• Hypersensitivity to any of the component of formulation.

• Patients with tuberculosis cutis, herpes simplex, varicella, herpes zoster, vaccinia and syphilis.

• Eczematous otitis externa with perforated eardrum.

• Ulcer (Bezet’s disease), burn (exceed 2°)

• Patients who have previously exhibited hypersensitivity to aminoglycoside antibiotic (such as streptomycin, neomycin, kanamycin and gentamicin) and bacitracin.


• Long-term continuous therapy, particularly occlusive dressings, should be avoided since it may cause side effects as systemic administration of corticosteroid.

Avoid long-term therapy: The overgrowth of non-susceptible organisms, including fungi, occasionally occurs with the use of topical antibiotic. If this occurs, or if irritation, sensitization, or superinfections develops, treatment should be discontinued and appropriate therapy instituted.


1. If the symptom aren’t being improved or are aggravated, discontinue the therapy.

2. If the symptom is improved, change this drug to other non-steroidal drug as soon as possible.


Adverse Effects

Sate and well tolerated. Rarely, some patients shows mild to moderate irritation (erythema and pruritus) that did not usually discontinuance of treatment.

Other dermal symptoms:

Long-term therapy may cause steroidal acne, steroidal skin (skin stropy, telangiectasis) and changes of the skin such as thinning, purpura, hirsutism and hypopigmentation. Such symptoms may occur slowly decrease the dosage of and change to non-steroidal drug.

HPA axis function:

long-term therapy or occlusive dressings may cause hypothalamus-pituitary (HPA) axis suppression.

Dosage & Administration

Apply to the affected area once to several times daily as directed by the Physician.

Storage/Handling Recommendations

Review Date

2016-12-01 08:11:57